Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) have earned a consensus recommendation of “Hold” from the nine brokerages that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. The average 12-month […]
